Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02287428 |
|---|---|
| Brief Title: | Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM |
| First Submitted : | October 29, 2014 |
| First Submitted that Met QC Criteria : | November 6, 2014 |
| First Posted : | November 10, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 14, 2023 |
| Last Update Posted : | June 15, 2023 |